Novo Nordisk A/S
NOVO-B
Rang in aandelen
#107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$39.74
Marktkapitalisatie
$175.38B
Verandering (1 dag)
1.28%
Verandering (1 jaar)
-25.58%
Land
DK
Handel Novo Nordisk A/S (NOVO-B)
Categorie
Healthcare
Aandelsplitsingen voor Novo Nordisk A/S (NOVO-B)
Het aandeel Novo Nordisk A/S (symbool: NOVO-B) heeft in totaal 6 splitsingen ondergaan.
De meest recente splitsing vond plaats op Sep 13, 2023.
Eén aandeel NOVO-B dat vóór Jun 04, 1991 werd gekocht, staat nu gelijk aan 207.2 aandelen NOVO-B.
De meest recente splitsing vond plaats op Sep 13, 2023.
Eén aandeel NOVO-B dat vóór Jun 04, 1991 werd gekocht, staat nu gelijk aan 207.2 aandelen NOVO-B.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2023-09-13 | 2:1 | x2 | x207.2 |
| 2014-01-02 | 5:1 | x5 | x103.6 |
| 2007-12-03 | 2:1 | x2 | x20.72 |
| 2001-04-04 | 5:1 | x5 | x10.36 |
| 1997-01-02 | 2:1 | x2 | x2.072 |
| 1991-06-04 | 259:250 | x1.036 | x1.036 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 4 | x15 |
US
|
|
| 7 | x432 |
US
|
|
| 0 | - |
US
|
|
| 7 | x226 |
US
|
|
| 2 | x10000 |
CH
|
